Effect of oral insulin on prevention of diabetes in relatives of patients with type 1 diabetes: A randomized clinical trial

Keyphrases

• Type I Diabetes 100%
• Type 1 Diabetes Mellitus (T1DM) 100%
• Diabetes Prevention 100%
• Randomized Clinical Trial 100%
• Patient Relatives 100%
• Oral Insulin 100%
• Diabetes 70%
• Placebo 30%
• Autoantibodies 30%
• Hazard Ratio 30%
• First-phase Insulin Secretion 30%
• Placebo Groups 30%
• Adverse Events 20%
• United States 10%
• Germany 10%
• Sweden 10%
• Australia 10%
• Clinical Effect 10%
• Canada 10%
• Non-Hispanic White 10%
• United Kingdom 10%
• Lifestyle Modification 10%
• New Zealand 10%
• Italy 10%
• P-53 10%
• Intravenous Glucose Tolerance Test 10%
• Finland 10%
• Antibody Profile 10%
• Normal Glucose Tolerance 10%
• Insulin Autoantibodies 10%
• Release Limits 10%
• Autoantibody Profile 10%
• Between-group Comparisons 10%

Medicine and Dentistry

• Randomized Clinical Trial 100%
• Patient with Type 1 Diabetes 100%
• Diabetes 100%
• Placebo 75%
• Autoantibodies 62%
• Insulin Dependent Diabetes Mellitus 50%
• Insulin Release 37%
• Hazard Ratio 37%
• Adverse Event 25%
• Infection 12%
• Diabetes Prevention 12%
• Lifestyle Modification 12%
• Glucose Tolerance 12%
• Intravenous Glucose Tolerance Test 12%